Literature DB >> 34496175

Somatic PIK3CA Mutations in Sporadic Cerebral Cavernous Malformations.

Matthieu Peyre1, Danielle Miyagishima1, Franck Bielle1, Françoise Chapon1, Michael Sierant1, Quitterie Venot1, Julie Lerond1, Pauline Marijon1, Samiya Abi-Jaoude1, Tuan Le Van1, Karim Labreche1, Richard Houlston1, Maxime Faisant1, Stéphane Clémenceau1, Anne-Laure Boch1, Aurelien Nouet1, Alexandre Carpentier1, Julien Boetto1, Angeliki Louvi1, Michel Kalamarides1.   

Abstract

BACKGROUND: Cerebral cavernous malformations (CCMs) are common sporadic and inherited vascular malformations of the central nervous system. Although familial CCMs are linked to loss-of-function mutations in KRIT1 (CCM1), CCM2, or PDCD10 (CCM3), the genetic cause of sporadic CCMs, representing 80% of cases, remains incompletely understood.
METHODS: We developed two mouse models harboring mutations identified in human meningiomas with the use of the prostaglandin D2 synthase (PGDS) promoter. We performed targeted DNA sequencing of surgically resected CCMs from patients and confirmed our findings by droplet digital polymerase-chain-reaction analysis.
RESULTS: We found that in mice expressing one of two common genetic drivers of meningioma - Pik3ca H1047R or AKT1 E17K - in PGDS-positive cells, a spectrum of typical CCMs develops (in 22% and 11% of the mice, respectively) instead of meningiomas, which prompted us to analyze tissue samples from sporadic CCMs from 88 patients. We detected somatic activating PIK3CA and AKT1 mutations in 39% and 1%, respectively, of lesion tissue from the patients. Only 10% of lesions harbored mutations in the CCM genes. We analyzed lesions induced by the activating mutations Pik3ca H1074R and AKT1 E17K in mice and identified the PGDS-expressing pericyte as the probable cell of origin.
CONCLUSIONS: In tissue samples from sporadic CCMs, mutations in PIK3CA were represented to a greater extent than mutations in any other gene. The contribution of somatic mutations in the genes that cause familial CCMs was comparatively small. (Funded by the Fondation ARC pour la Recherche contre le Cancer and others.).
Copyright © 2021 Massachusetts Medical Society.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34496175      PMCID: PMC8606022          DOI: 10.1056/NEJMoa2100440

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  43 in total

1.  Klippel-Trenaunay syndrome belongs to the PIK3CA-related overgrowth spectrum (PROS).

Authors:  Hassan Vahidnezhad; Leila Youssefian; Jouni Uitto
Journal:  Exp Dermatol       Date:  2015-10-13       Impact factor: 3.960

2.  Somatic MAP2K1 Mutations Are Associated with Extracranial Arteriovenous Malformation.

Authors:  Javier A Couto; August Y Huang; Dennis J Konczyk; Jeremy A Goss; Steven J Fishman; John B Mulliken; Matthew L Warman; Arin K Greene
Journal:  Am J Hum Genet       Date:  2017-02-09       Impact factor: 11.025

3.  Cytoplasmic translocation of Olig2 in adult glial progenitors marks the generation of reactive astrocytes following autoimmune inflammation.

Authors:  Riccardo Cassiani-Ingoni; Turhan Coksaygan; Haipeng Xue; Susan A Reichert-Scrivner; Heinz Wiendl; Mahendra S Rao; Tim Magnus
Journal:  Exp Neurol       Date:  2006-06-30       Impact factor: 5.330

4.  Selective vulnerability of the primitive meningeal layer to prenatal Smo activation for skull base meningothelial meningioma formation.

Authors:  Julien Boetto; Caroline Apra; Franck Bielle; Matthieu Peyre; Michel Kalamarides
Journal:  Oncogene       Date:  2018-05-22       Impact factor: 9.867

5.  Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer.

Authors:  Fabrice André; Eva Ciruelos; Gabor Rubovszky; Mario Campone; Sibylle Loibl; Hope S Rugo; Hiroji Iwata; Pierfranco Conte; Ingrid A Mayer; Bella Kaufman; Toshinari Yamashita; Yen-Shen Lu; Kenichi Inoue; Masato Takahashi; Zsuzsanna Pápai; Anne-Sophie Longin; David Mills; Celine Wilke; Samit Hirawat; Dejan Juric
Journal:  N Engl J Med       Date:  2019-05-16       Impact factor: 91.245

6.  Molecular characterization and developmental expression pattern of the chicken apolipoprotein D gene: implications for the evolution of vertebrate lipocalins.

Authors:  María D Ganfornina; Diego Sánchez; Aldo Pagano; Laura Tonachini; Fiorella Descalzi-Cancedda; Salvador Martínez
Journal:  Dev Dyn       Date:  2005-01       Impact factor: 3.780

Review 7.  Recent insights into cerebral cavernous malformations: the molecular genetics of CCM.

Authors:  Florence Riant; Francoise Bergametti; Xavier Ayrignac; Gwenola Boulday; Elisabeth Tournier-Lasserve
Journal:  FEBS J       Date:  2010-01-22       Impact factor: 5.542

8.  Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas.

Authors:  Victoria E Clark; Akdes Serin Harmancı; Hanwen Bai; Mark W Youngblood; Tong Ihn Lee; Jacob F Baranoski; A Gulhan Ercan-Sencicek; Brian J Abraham; Abraham S Weintraub; Denes Hnisz; Matthias Simon; Boris Krischek; E Zeynep Erson-Omay; Octavian Henegariu; Geneive Carrión-Grant; Ketu Mishra-Gorur; Daniel Durán; Johanna E Goldmann; Johannes Schramm; Roland Goldbrunner; Joseph M Piepmeier; Alexander O Vortmeyer; Jennifer Moliterno Günel; Kaya Bilgüvar; Katsuhito Yasuno; Richard A Young; Murat Günel
Journal:  Nat Genet       Date:  2016-08-22       Impact factor: 38.330

9.  Developmental timing of CCM2 loss influences cerebral cavernous malformations in mice.

Authors:  Gwénola Boulday; Noemi Rudini; Luigi Maddaluno; Anne Blécon; Minh Arnould; Alain Gaudric; Françoise Chapon; Ralf H Adams; Elisabetta Dejana; Elisabeth Tournier-Lasserve
Journal:  J Exp Med       Date:  2011-08-22       Impact factor: 14.307

10.  Endothelial cell clonal expansion in the development of cerebral cavernous malformations.

Authors:  Matteo Malinverno; Claudio Maderna; Abdallah Abu Taha; Monica Corada; Fabrizio Orsenigo; Mariaelena Valentino; Federica Pisati; Carmela Fusco; Paolo Graziano; Monica Giannotta; Qing Cissy Yu; Yi Arial Zeng; Maria Grazia Lampugnani; Peetra U Magnusson; Elisabetta Dejana
Journal:  Nat Commun       Date:  2019-06-24       Impact factor: 14.919

View more
  10 in total

Review 1.  Genetics of brain arteriovenous malformations and cerebral cavernous malformations.

Authors:  Hiroki Hongo; Satoru Miyawaki; Yu Teranishi; Daiichiro Ishigami; Kenta Ohara; Yu Sakai; Daisuke Shimada; Motoyuki Umekawa; Satoshi Koizumi; Hideaki Ono; Hirofumi Nakatomi; Nobuhito Saito
Journal:  J Hum Genet       Date:  2022-07-13       Impact factor: 3.755

2.  Natural history of familial cerebral cavernous malformation syndrome in children: a multicenter cohort study.

Authors:  Ana Filipa Geraldo; Cesar Augusto P F Alves; Aysha Luis; Domenico Tortora; Joana Guimarães; Daisy Abreu; Sofia Reimão; Marco Pavanello; Patrizia de Marco; Marcello Scala; Valeria Capra; Rui Vaz; Andrea Rossi; Erin Simon Schwartz; Kshitij Mankad; Mariasavina Severino
Journal:  Neuroradiology       Date:  2022-10-06       Impact factor: 2.995

Review 3.  Rapamycin in Cerebral Cavernous Malformations: What Doses to Test in Mice and Humans.

Authors:  Matthew J Hagan; Robert Shenkar; Abhinav Srinath; Sharbel G Romanos; Agnieszka Stadnik; Mark L Kahn; Douglas A Marchuk; Romuald Girard; Issam A Awad
Journal:  ACS Pharmacol Transl Sci       Date:  2022-04-25

4.  The onset of PI3K-related vascular malformations occurs during angiogenesis and is prevented by the AKT inhibitor miransertib.

Authors:  Piotr Kobialka; Helena Sabata; Sandra D Castillo; Mariona Graupera; Odena Vilalta; Leonor Gouveia; Ana Angulo-Urarte; Laia Muixí; Jasmina Zanoncello; Oscar Muñoz-Aznar; Nagore G Olaciregui; Lucia Fanlo; Anna Esteve-Codina; Cinzia Lavarino; Biola M Javierre; Veronica Celis; Carlota Rovira; Susana López-Fernández; Eulàlia Baselga; Jaume Mora
Journal:  EMBO Mol Med       Date:  2022-06-13       Impact factor: 14.260

Review 5.  Cerebral Cavernous Malformation Pathogenesis: Investigating Lesion Formation and Progression with Animal Models.

Authors:  Chelsea M Phillips; Svetlana M Stamatovic; Richard F Keep; Anuska V Andjelkovic
Journal:  Int J Mol Sci       Date:  2022-04-30       Impact factor: 6.208

6.  Neuropilin-1 deficiency in vascular smooth muscle cells is associated with hereditary hemorrhagic telangiectasia arteriovenous malformations.

Authors:  Sreenivasulu Kilari; Ying Wang; Avishek Singh; Rondell P Graham; Vivek Iyer; Scott M Thompson; Michael S Torbenson; Debabrata Mukhopadhyay; Sanjay Misra
Journal:  JCI Insight       Date:  2022-05-09

Review 7.  Cerebral Cavernous Malformation: Immune and Inflammatory Perspectives.

Authors:  Tianqi Tu; Zhenghong Peng; Jian Ren; Hongqi Zhang
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

8.  Case Report of Fibro-Adipose Vascular Anomaly (FAVA) with Activating Somatic PIK3CA Mutation.

Authors:  Jordan H Driskill; Helena Hwang; Alexandra K Callan; Dwight Oliver
Journal:  Case Rep Genet       Date:  2022-08-02

9.  Next-Generation Sequencing Advances the Genetic Diagnosis of Cerebral Cavernous Malformation (CCM).

Authors:  Valerio Benedetti; Rosalia Canzoneri; Andrea Perrelli; Carlo Arduino; Andrea Zonta; Alfredo Brusco; Saverio Francesco Retta
Journal:  Antioxidants (Basel)       Date:  2022-06-29

10.  Inflammation and neutrophil extracellular traps in cerebral cavernous malformation.

Authors:  Anthony C Y Yau; Maria Ascencion Globisch; Favour Chinyere Onyeogaziri; Lei L Conze; Ross Smith; Suvi Jauhiainen; Monica Corada; Fabrizio Orsenigo; Hua Huang; Melanie Herre; Anna-Karin Olsson; Matteo Malinverno; Veronica Sundell; Behnam Rezai Jahromi; Mika Niemelä; Aki Laakso; Cecilia Garlanda; Alberto Mantovani; Maria Grazia Lampugnani; Elisabetta Dejana; Peetra U Magnusson
Journal:  Cell Mol Life Sci       Date:  2022-03-25       Impact factor: 9.207

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.